Best evidence statement (BESt). Pharmacological treatment of aggression in children with attention deficit hyperactivity disorder (ADHD). Cincinnati Children's Hospital Medical Center. NGC:007673

Publication Details

Author(s):

• AHRQ (US) - Agency for Healthcare Research and Quality

Country(ies) of application:

• United States

Language(s):

• English

Type of Publication:

Guideline Clearing Report

Primary Contact:

Jean R. Slutsky, P.A., M.S.P.H.
jslutsky@ahrq.gov

Publication URL:

Open Publication URL in a new window

Publication Scope:

• Management

Publication Status:

Published

Date of publication:

Nov 18, 2009

Due for Review:

-

Diseases / Conditions Addressed

MeSH Terms addressed:

• Mental Disorders (F03)
  • Mental Disorders Diagnosed in Childhood (F03.550)
    • Attention Deficit and Disruptive Behavior Disorders (F03.550.150)
• Pharmacologic Actions (D27.505)
  • Central Nervous System Agents (D27.505.954.427)
• Behaviour and Behaviour Mechanisms (F01)
  • Child Behaviour (F01.145.179)
  • Social Behavior (F01.145.813)
    • Aggression (F01.145.813.045)
• Pediatrics (G02.403.776.610)

Guideline key questions